Disability due to rheumatic diseases in the city of Junín, Argentina

被引:0
|
作者
Nauan Fara
Orlando Recchia
Gabriel Sequeira
Karina Sanchez
机构
[1] Instituto Médico de la Comunidad,
[2] Junta Evaluadora de Discapacidad,undefined
[3] Municipalidad de Junín,undefined
[4] Centro Dermatológico Schejtman,undefined
[5] Dirección para las Personas con Discapacidad,undefined
[6] Municipalidad de Junín,undefined
来源
Rheumatology International | 2019年 / 39卷
关键词
Disability; Disability certificate; Rheumatic diseases; Osteoarthritis; Rheumatoid arthritis;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the study is to analyze the characteristics of patients with rheumatic diseases applying for a Disability Certificate (DC). Every application for DC filed by patients of 16 years of age and older in the Health Secretariat of Junin, between 2012 and 2016, was analyzed regarding age, gender, rheumatic disease as the cause of disability, employment status, and health insurance coverage. Applications were examined as per two elements: inflammatory articular or systemic disease (IASD) versus degenerative diseases, regional or generalized pain syndromes (non-IASD). Based on the DCs accepted, a Disability Prevalence Rate (DPR) was estimated and the most common causes of disability were determined. Out of 400 applications, 68% belonged to women; applicants’ median age was 61 years, only 27% were working, 42% were for DC renewal, and 46% were IASD. Overall, 83% of the applications submitted were accepted. Those patients with accepted DC applications were older (median age 62 vs 55; p < 0.001), had health insurance coverage (90% vs 65%; p <0.001), were applying for DC renewal (49% vs 12%; p < 0.001) and more frequently presented a IASD (52% vs 17%; p < 0.001). 48% of accepted DC applications had osteoarthritis (OA), 36% rheumatoid arthritis (RA), 6% psoriatic arthritis (PsA), 5% systemic lupus erythematosus (SLE) and 2% ankylosing spondylitis (AS). The DPR was 0.5%. Overall, the accepted applications for DC belong to older patients with health insurance coverage, who were submitting an application for DC renewal and suffer from a IASD. OA, RA, PsA, SLE and AS were the five most common causes of disability.
引用
收藏
页码:729 / 733
页数:4
相关论文
共 29 条
  • [21] Modeling quality of life in patients with rheumatic diseases: the role of pain catastrophizing, fear-avoidance beliefs, physical disability, and depression
    Shim, Eun-Jung
    Hahm, Bong-Jin
    Go, Dong Jin
    Lee, Kwang-Min
    Noh, Hae Lim
    Park, Seung-Hee
    Song, Yeong Wook
    DISABILITY AND REHABILITATION, 2018, 40 (13) : 1509 - 1516
  • [22] Causes of mortality due to rheumatic diseases in Jerez de los Caballeros(Badajoz) during the 19th century
    Peral Pacheco, Diego
    Javier Suarez-Guzman, Francisco
    REUMATOLOGIA CLINICA, 2016, 12 (02): : 78 - 80
  • [23] Crosstalk between N6-methyladenosine modification and ncRNAs in rheumatic diseases: therapeutic and diagnostic implications
    Jianting Wen
    Jian Liu
    Lei Wan
    Yue Sun
    Fanfan Wang
    Inflammation Research, 2025, 74 (1)
  • [24] SINGLE-DOSE AND STEADY STATE PHARMACOKINETICS OF CSA AND TWO MAIN PRIMARY METABOLITES, AM1 AND AM4N IN PATIENTS WITH RHEUMATIC/AUTOIMMUNE DISEASES
    Suchy, David
    Dostalek, Miroslav
    Perinova, Ilona
    Brozmanova, Hana
    Grundmann, Milan
    Vyskocil, Vaclav
    Mayer, Otto
    BIOMEDICAL PAPERS-OLOMOUC, 2011, 155 (03): : 269 - 274
  • [25] NMDA Receptors in Health and Diseases: New Roles and Signaling Pathways-Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Autoantibodies as Potential Biomarkers of Fatigue in Patients with Rheumatic Diseases
    Marinoska, Tatjana
    Moeckel, Tamara
    Triantafyllias, Konstantinos
    Boegel, Sebastian
    Dreher, Matthias
    Luessi, Felix
    Schwarting, Andreas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [26] Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign
    Touma, Zahi
    Gladman, Dafna D.
    Urowitz, Murray B.
    CURRENT OPINION IN RHEUMATOLOGY, 2013, 25 (02) : 164 - 170
  • [27] Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients
    Aikawa, N. E.
    Trudes, G.
    Campos, L. M. A.
    Pereira, R. M. R.
    Moraes, J. C. B.
    Ribeiro, A. C.
    Miraglia, J.
    Timenetsky, M. do Carmo S.
    Bonfa, E.
    Silva, C. A.
    LUPUS, 2013, 22 (13) : 1394 - 1398
  • [28] Longitudinal monitor of Jun N-terminal kinase pathway associated phosphatase reflects clinical efficacy to triple conventional disease-modifying anti-rheumatic drugs treatment in rheumatoid arthritis patients
    Dongming Song
    Xiaoxia Zhu
    Fangming Wang
    Jian Sun
    Inflammopharmacology, 2021, 29 : 1131 - 1138
  • [29] Longitudinal monitor of Jun N-terminal kinase pathway associated phosphatase reflects clinical efficacy to triple conventional disease-modifying anti-rheumatic drugs treatment in rheumatoid arthritis patients
    Song, Dongming
    Zhu, Xiaoxia
    Wang, Fangming
    Sun, Jian
    INFLAMMOPHARMACOLOGY, 2021, 29 (04) : 1131 - 1138